Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 173 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Heart failure hospitalization with DPP-4 inhibitors: A systematic review and meta-analysis of randomized controlled trials

Singh Awadhesh Kumar, Singh Ritu

Year : 2019| Volume: 23| Issue : 1 | Page no: 128-133

   This article has been cited by
1 Sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase -4 inhibitors and the risk of heart failure: A nationwide cohort study of older adults with diabetes mellitus
Michael Fralick,Michael Colacci,Deva Thiruchelvam,Tara Gomes,Donald A Redelmeier
Diabetes, Obesity and Metabolism. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Effect of dipeptidyl peptidase 4 inhibitors on cardiovascular events in type-2 diabetes patients with renal impairment: A systematic review and meta-analysis
Maneesha Khalse,B Ganapathy
Indian Journal of Endocrinology and Metabolism. 2020; 24(2): 143
[Pubmed]  [Google Scholar] [DOI]
3 Tratamiento médico de la diabetes mellitus tipo 2: recomendaciones del Grupo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna
F.J. Carrasco-Sánchez,J.M. Fernández-Rodríguez,J. Ena,R. Gómez-Huelgas,J. Carretero-Gómez
Revista Clínica Española. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Medical treatment of type 2 diabetes mellitus: Recommendations of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine
F.J. Carrasco-Sánchez,J.M. Fernández-Rodríguez,J. Ena,R. Gómez-Huelgas,J. Carretero-Gómez
Revista Clínica Española (English Edition). 2020;
[Pubmed]  [Google Scholar] [DOI]
5 Sodium-glucose co-transporter 2 inhibitors and heart failure—the present and the future
Melanie Nana,Holly Morgan,L. N. Rao Bondugulapati
Heart Failure Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era
Faisal A. Aljehani,Katalina Funke,Kathie L. Hermayer
The American Journal of the Medical Sciences. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Sitagliptin protects liver against aflatoxin B1-induced hepatotoxicity through upregulating Nrf2/ARE/HO-1 pathway
Yujiang Ji,Sanatkumar B. Nyamagoud,Nagaraja SreeHarsha,Anurag Mishra,Shiva K. Gubbiyappa,Yogendra Singh
BioFactors. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article